Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernesto Freire

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Chemical Biology & Drug Design|June 22, 2007
Compensating enthalpic and entropic changes hinder binding affinity optimizationVirginie Lafont, Anthony A Armstrong, Hiroyasu Ohtaka, et al.
Analytical Biochemistry|May 12, 2018
Long term stability of a HIV-1 neutralizing monoclonal antibody using isothermal calorimetryBenjamin R Clarkson, Rajoshi Chaudhuri, Arne Schön, et al.
Chemical Biology & Drug Design|July 10, 2008
Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CL(pro)Usman Bacha, Jennifer Barrila, Sandra B Gabelli, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2009
New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitorsThomas Regnier, Diganta Sarma, Koushi Hidaka, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|December 1, 2004
Search for substrate-based inhibitors fitting the S2' space of malarial aspartic protease plasmepsin IIAiko Kiso, Koushi Hidaka, Tooru Kimura, et al.
Analytical Biochemistry|August 5, 2015
Denatured state aggregation parameters derived from concentration dependence of protein stabilityArne Schön, Benjamin R Clarkson, Rogelio Siles, et al.
Current Protein & Peptide Science|February 18, 2004
Interactions of HIV-1 proteins gp120 and Nef with cellular partners define a novel allosteric paradigmStephanie A Leavitt, Arne SchOn, Jeffrey C Klein, et al.
Proteins|April 23, 2004
A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 proteaseSonia Vega, Lin-Woo Kang, Adrian Velazquez-Campoy, et al.
AIDS Reviews|November 6, 2003
Protease inhibition in African subtypes of HIV-1Adrián Velázquez-Campoy, Sonia Vega, Erin Fleming, et al.
Retrovirology|January 16, 2014
HIV-1 Vif N-terminal motif is required for recruitment of Cul5 to suppress APOBEC3Sean L Evans, Arne Schön, Qimeng Gao, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Chemical Biology & Drug Design|June 22, 2007
Compensating enthalpic and entropic changes hinder binding affinity optimizationVirginie Lafont, Anthony A Armstrong, Hiroyasu Ohtaka, et al.
Analytical Biochemistry|May 12, 2018
Long term stability of a HIV-1 neutralizing monoclonal antibody using isothermal calorimetryBenjamin R Clarkson, Rajoshi Chaudhuri, Arne Schön, et al.
Chemical Biology & Drug Design|July 10, 2008
Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CL(pro)Usman Bacha, Jennifer Barrila, Sandra B Gabelli, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2009
New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitorsThomas Regnier, Diganta Sarma, Koushi Hidaka, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|December 1, 2004
Search for substrate-based inhibitors fitting the S2' space of malarial aspartic protease plasmepsin IIAiko Kiso, Koushi Hidaka, Tooru Kimura, et al.
Analytical Biochemistry|August 5, 2015
Denatured state aggregation parameters derived from concentration dependence of protein stabilityArne Schön, Benjamin R Clarkson, Rogelio Siles, et al.
Current Protein & Peptide Science|February 18, 2004
Interactions of HIV-1 proteins gp120 and Nef with cellular partners define a novel allosteric paradigmStephanie A Leavitt, Arne SchOn, Jeffrey C Klein, et al.
Proteins|April 23, 2004
A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 proteaseSonia Vega, Lin-Woo Kang, Adrian Velazquez-Campoy, et al.
AIDS Reviews|November 6, 2003
Protease inhibition in African subtypes of HIV-1Adrián Velázquez-Campoy, Sonia Vega, Erin Fleming, et al.
Retrovirology|January 16, 2014
HIV-1 Vif N-terminal motif is required for recruitment of Cul5 to suppress APOBEC3Sean L Evans, Arne Schön, Qimeng Gao, et al.
Pageof 11